1. Home
  2. Browse
  3. Cardiology
  4. Resources
  5. Drug-Induced Cardiovascular Disease

Drug-Induced Cardiovascular Disease

181 - 195 of 255 Results
Sort Results:
Guideline: Implementing the Key Action Statements: An Algorithm and Explanation for Process of Care for the Evaluation, Diagnosis, Treatment, and Monitoring of ADHD in Children and Adolescents (2011) December 2011
Guideline: Diagnosis and Management of Attention Deficit Hyperactivity Disorder in Primary Care for School-Age Children and Adolescents (2010) December 2011
Commentary: Diabetes Meds and Cardiovascular Risk November 2011
Article: You'll hear claims that gliptins (Januvia, etc) decrease cardiovascular risk in diabetes patients November 2011
Article: stronger warnings about Seroquel and QT prolongation September 2011
Commentary: QT Prolongation, Torsades de Pointes, & Medication Safety September 2011
Commentary: New Vardenafil Formulation: Staxyn August 2011
Chart: Phosphodiesterase 5 (PDE5) Inhibitor Interactions August 2011
Guideline: Treating Tobacco Use and Dependence (2008 Update) August 2011
Guideline: Use of Sildenafil (Viagra) in Patients With Cardiovascular Disease (1999) August 2011
PL Voices: New Warnings About Chantix August 2011
Commentary: Chantix (Varenicline): New Safety Information and Instructions For Use August 2011
Commentary: Chantix (Varenicline) and Risk of Cardiovascular Events August 2011
Article: new warnings about Chantix and an increased risk of cardiac events in patients with heart disease August 2011
Article: Staxyn (STAX-in), a new orally disintegrating tablet version of vardenafil (Levitra) August 2011